We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bugworks

News List

Bugworks Research Announces the First in Human Phase 1 Study of BWC0977 for the Treatment of Critical Bacterial Infections prnasia
November 08, 2021
Bugworks research today announced that the first human dose was administered in a Phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoisomerase inhibitor (NBTI)...
GARDP and Bugworks sign MoU to develop antibiotics for serious bacterial infections expresspharma
August 31, 2020
The collaboration includes working together for the preparation of regulatory strategies, in particular for clinical development programmes and post-approval studies.
Bugworks Research raises $9M in series A funding biospectrumasia
August 20, 2018
Bugworks' novel bacterial topoisomerase inhibitor (NBTI) is highly effective against a very broad spectrum of multi-drug resistant bacterial pathogens